ES320356A1 - Procedimiento para la preparaciën de pastillas medicinales comestibles - Google Patents

Procedimiento para la preparaciën de pastillas medicinales comestibles

Info

Publication number
ES320356A1
ES320356A1 ES0320356A ES320356A ES320356A1 ES 320356 A1 ES320356 A1 ES 320356A1 ES 0320356 A ES0320356 A ES 0320356A ES 320356 A ES320356 A ES 320356A ES 320356 A1 ES320356 A1 ES 320356A1
Authority
ES
Spain
Prior art keywords
pharmaceutical
demulcent
core
liquid
pastilles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES0320356A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES320356A1 publication Critical patent/ES320356A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES0320356A 1964-12-05 1965-12-04 Procedimiento para la preparaciën de pastillas medicinales comestibles Expired ES320356A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4957264A GB1060258A (en) 1964-12-05 1964-12-05 Improvements in or relating to pharmaceutical pastilles

Publications (1)

Publication Number Publication Date
ES320356A1 true ES320356A1 (es) 1966-09-01

Family

ID=10452785

Family Applications (1)

Application Number Title Priority Date Filing Date
ES0320356A Expired ES320356A1 (es) 1964-12-05 1965-12-04 Procedimiento para la preparaciën de pastillas medicinales comestibles

Country Status (3)

Country Link
ES (1) ES320356A1 (fr)
FR (1) FR5366M (fr)
GB (1) GB1060258A (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4260596A (en) * 1979-08-13 1981-04-07 Bristol-Myers Company Edible unit dosage form consisting of outer mannitol shell and inner liquid or gel center and method for manufacturing the same
US4428927A (en) 1981-05-11 1984-01-31 R. P. Scherer Corporation Masticatory soft elastic gelatin capsules and method for the manufacture thereof
US4532126A (en) * 1982-05-07 1985-07-30 R. P. Scherer Corporation Masticatory soft elastic gelatin capsules and method for the manufacture thereof
FR2535608B1 (fr) * 1982-11-04 1986-05-02 Dubarry Philippe Capsule a base de xylitol adapte a la succion par l'homme, son procede d'obtention et dispositif pour la mise en oeuvre de ce procede
US4975270A (en) * 1987-04-21 1990-12-04 Nabisco Brands, Inc. Elastomer encased active ingredients
DE3914170C1 (en) * 1989-04-28 1990-11-22 Capsoid Pharma Gmbh, 7128 Lauffen, De Pastille prepn. contg. vitamin(s) etc. - by dosing concave mould with liq. sol or gel mixt. contg. active ingredient, gelatin and water
FR2666227A1 (fr) * 1990-09-05 1992-03-06 Darcy Laboratoires Composition therapeutique notamment pour le traitement des affections de la cavite buccale.
US5300305A (en) * 1991-09-12 1994-04-05 The Procter & Gamble Company Breath protection microcapsules
CA2125483A1 (fr) * 1991-12-11 1993-06-24 Mary Ann Hunter Chlorure de cetylpyridinium et bromure de domiphene dans un solvant organique
US5620707A (en) * 1993-06-29 1997-04-15 The Procter & Gamble Company Beadlets for customization of flavor and sweetener in a beverage
US5641512A (en) * 1995-03-29 1997-06-24 The Procter & Gamble Company Soft gelatin capsule compositions
JPH11502839A (ja) * 1995-03-29 1999-03-09 ザ、プロクター、エンド、ギャンブル、カンパニー 鎮咳剤マイクロカプセル
EP1559418A1 (fr) * 2000-06-26 2005-08-03 EpiCept Corporation Compositions pour le traitement analgesique de la muqueuse
GB2412865A (en) * 2004-04-07 2005-10-12 Atulkumar Sumanbhai Patel Cough mixture comprising ipecacuanha and guaifenesin
ATE479336T1 (de) * 2005-03-04 2010-09-15 Wrigley W M Jun Co Gefüllte geleebonbons
EP2832353B1 (fr) 2012-03-28 2018-07-18 Taiko Pharmaceutical Co., Ltd. Composition de médicament et capsule molle la contenant

Also Published As

Publication number Publication date
FR5366M (fr) 1967-10-16
GB1060258A (en) 1967-03-01

Similar Documents

Publication Publication Date Title
ES320356A1 (es) Procedimiento para la preparaciën de pastillas medicinales comestibles
DE69419019T2 (de) Gelatinekaiseln die eine hochdosierte acetaminophenlösung enthalten
GB1390772A (en) Oral narcotic composition
ES424533A1 (es) Metodo de prolongar la disponibilidad de sustancias farmaco-logicamente activas incluidas en composiciones farmaceuticasa base de alcohol alifatico e hidroxialcohilcelulosa.
KR830005854A (ko) 알카리성 진통제 캡슐의 제조방법
Boggan et al. Δ 9-tetrahydrocannabinol effect on audiogenic seizure susceptibility
KR850700109A (ko) 항 이뇨제 ddavp 및 그의 제조 방법
CA2027360A1 (fr) Soie medicamentee au gout masque
Lasagna Thalidomide—a new nonbarbiturate sleep-inducing drug
US3211614A (en) Enema-type laxative composition
GB1183403A (en) Antitussive Medicament with Prolonged Effect
Pinchasi et al. On the interaction of drugs with the cholinergic nervous system: II. Cross-tolerance between phencyclidine derivatives and cholinergic drugs
KR970701047A (ko) 진해제 및 벤지드아민을 함유하는 진해제 조성물(antitussive composition containing an antitussive and benzydamine)
Workmon et al. A clinical evaluation of nefopam hydrochloride (Acupan): a new analgesic.
Ehlers THE MODERATELY AND SEVERELY RETARDED CHILD: MATERNAL PERCEPTIONS OF RETARDATION AND SUBSEQUENT SEEKING AND USING SERVICES RENDERED BY A COMMUNITY AGENCY.
Johanson The choice of cocaine by rhesus monkeys as a function of dosage.
DD279405A1 (de) Verfahren zur herstellung eines parenteral applizierbaren analgetikums/antipyretikums
DE2135259A1 (fr)
GB1004077A (en) Pharmaceutical compositions containing dibenzoquinolizines
FR2117796A6 (en) Vincine derivs - used as antitussives, sedatives local anaesthetics and analgesics
CHONG YAP, J.
Pronko WESTLEY, WILLIAM A." Violence and the Police"(Book Review)
JPS54105237A (en) Analgesic agent containing nalorphine-6-glucuronide
Douglas Drug enhancement of inhibition.
ES483500A1 (es) Un metodo de preparar una sal de glaucina